FDA allows emergency use of remdesivir to treat coronavirus patients after promising study
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
President Trump announced Friday that the Food and Drug Administration (FDA) has authorized the emergency use of Gilead Science’s experimental antiviral drug remdesivir to treat coronavirus patients after early results of a clinical study indicated the drug helps speed recovery.
Trump announced the news at the White House alongside Gilead CEO Daniel O’Day and FDA Commissioner Stephen Hahn.
“FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step forward in battling COVID-19 and another example of the Trump Administration moving as quickly as possible to use science to save lives,” Health and Human Services Secretary Alex Azar said in a statement.
“NIH, FDA, and scientists across America and around the world have worked tirelessly with patients to get …continued .
[Source: Fox News]